Hoth Therapeutics Inc (HOTH)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -326.58 | -287.227 | -461.377 | -178.19 | -176.411 | -128.167 | -96.382 |
Return on Equity (%) | -340.372 | -372.816 | -604.077 | -204.431 | -197.054 | -151.583 | -112.586 |
Return on Invested Capital (%) | -316.047 | -372.816 | -656.402 | -228.831 | -209.606 | -157.157 | -110.898 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.184 | 0.019 | 0.181 | 0.346 | 0.412 | 1.552 | 2.028 |
Earnings Per Share | -0.313 | -0.305 | -0.583 | -0.536 | -0.597 | -3.446 | -1.805 |
Cash Per Share | 0.191 | 0.035 | 0.128 | 0.196 | 0.356 | 1.948 | 2.138 |
Working Capital Per Share | 0.183 | 0.019 | 0.166 | 0.333 | 0.405 | 1.618 | 2.013 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.313 | -0.305 | -0.583 | -0.536 | -0.597 | -3.446 | -1.805 |
EBITDA Per Share | -0.313 | -0.305 | -0.583 | -0.536 | -0.597 | -3.446 | -1.805 |
Free Cash Flow Per Share | -0.266 | -0.306 | -0.576 | -0.523 | -0.592 | -3.423 | -1.805 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 4,71M | 5,07M | 10,12M | 13,44M | 23,97M | N/A | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 5,32M |
Ratio cours/bénéfice | -0,69 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0,58 |
Ratio prix/valeur comptable | 0,61 |
Rendement de dividende | - |
Actions en circulation | 6,9M |
Volume moyen (1 semaine) | 85,64k |
Volume moyen (1 mois) | 150,12k |
Variation sur 52 semaines | -37,90% |
Plus haut sur 52 semaines | 1,73 |
Plus bas sur 52 semaines | 0,58 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales